Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
Related Posts
TIGS and ICAR – IIRR sign MoU
📝 TIGS and ICAR - IIRR ink MoU! Climate change presents a significant... read more
कोरोना के नए वैरिएंट
टाटा इंस्टीट्यूट फॉर जेनेटिक्स एंड सोसाइटी के निदेशक राकेश मिश्रा का कहना... read more
Our research is aimed at making treatment for rare genetic diseases affordable
In an exclusive interview to Gunjan Sharma from the HealthPost, Dr. Rakesh... read more
Impact of Covid ‘is down but not out’, do not be careless: Health experts
In an exclusive interview to ANI, the Director of Tata Institute for... read more
Student visit – St. Joesph’s College, Bengaluru
A day well spent! On the occasion of National Science Day and Rare... read more
TIGS scientists present their work at International conference on Genetics and Genomics in Health and Diseases
Scientists from TIGS presented their work at the recently concluded 8th Annual... read more
Key insights of REDRESS 2023 featured in Biospectrum India
Rare Genetic Diseases Research Summit (REDRESS) 2023, an indigenous and recurrent platform... read more
Talk at the roundtable on “One Health, Disease Surveillance and Pandemic Preparedness”.
Dr. Rakesh Mishra, Director TIGS gave a talk on 'The approach of... read more
Health expert calls for reducing booster dose gap from 9 to 6 months
Director of Tata Institute for Genetics and Society (TIGS), Bengaluru, Dr Rakesh... read more
MoU signing with ICAR – Indian Institute of Seed Sciences (IISS)
We are pleased to host a delegation from ICAR-Indian Institute of Seed... read more